Stock Market Today, May 26: Soaring Tech Stocks Push S&P 500 and Nasdaq to New Highs

The S&P 500 rose 0.61% to a fresh record 7,519.12 and the Nasdaq climbed 1.19% to 26,656.18, driven by a powerful chip-led rally led by Micron, which jumped over 19% and briefly topped a $1 trillion valuation. AI-linked semiconductors including AMD and Qualcomm also advanced, while the Dow fell 0.23% as UnitedHealth and Merck dragged on healthcare. Oil prices and Treasury yields declined amid optimism over U.S.-Iran negotiations, while inflation concerns and consumer pullback added a cautious backdrop.

Analysis

This is a classic narrow-leadership tape where index strength masks deteriorating breadth beneath the surface. When a few high-beta chip names and AI proxies do the heavy lifting, the first-order trade is obvious, but the second-order risk is crowding: passive inflows, dealer gamma, and momentum systems can keep extending the move for days or weeks even as the marginal buyer becomes more fragile. That makes the current rally more durable in the short term than bears expect, but also more vulnerable to a sharp air-pocket if the chip complex stalls.

MU looks like the cleanest expression of the current setup because semis are being rewarded not just for earnings power, but for narrative convexity tied to AI capex. The more interesting read-through is to supply chain adjacencies: if memory and AI accelerators remain the market’s preferred liquid beta, then the next beneficiaries are likely the pick-and-shovel names with the tightest exposure to advanced packaging, foundry utilization, and enterprise networking. By contrast, the underperformance in healthcare is less about sector fundamentals and more about rotational funding pressure, which can persist until yields stabilize or growth leadership broadens.

The macro backdrop is mixed in a way that supports near-term risk-on, but not a clean all-clear. Falling yields and lower oil are supportive for multiples, yet they can reverse quickly if geopolitical headlines deteriorate or if the inflation narrative snaps back from consumer stress into higher pass-through pricing. The bigger contrarian point is that inflation-sensitive households cutting spending is usually a lagging demand warning; if that starts to hit retail earnings, the market may rotate from “soft landing” into “earnings recession” far faster than consensus expects.

I would not chase the broad index here; the better edge is in relative value and hedged expressions. The market is rewarding AI exposure, but the concentration trade is getting crowded enough that a single guide-down or capex pause could hit the group hard. That creates attractive asymmetry for hedged longs in the strongest semis versus shorts in the most vulnerable defensive/funding sources.

Key Decisions for Investors

• Long MU vs short XLV for 2-6 weeks: semis retain momentum and earnings leverage while healthcare is still a funding source; target 8-12% relative outperformance, stop if breadth rotates back into defensives.
• Buy AMD call spreads 1-2 months out: use upside participation in AI-beta continuation while capping premium decay; attractive if the chip rally extends another 5-8% before a consolidation.
• Pair long MU / short QCOM if you want the highest-conviction AI-memory versus handset cycle separation; risk/reward favors MU as the cleaner beneficiary of capex enthusiasm over the next quarter.
• Reduce unhedged index beta; if staying long equities, finance with a partial short in UNH or the broader healthcare sleeve over the next 1-3 weeks, since the sector is acting as a crowding-release valve rather than a fundamental short.
• Consider a short-dated downside hedge on NVDA or SOXX after any further gap-up: the tape is supporting semis, but leadership is getting concentrated enough that a 3-5% sector pullback is the most likely near-term disruption.